Subcutaneous sumatriptan in the clinical setting: The first 50 consecutive patients with acute migraine in a pediatric neurology office practice

Headache

Volumn 36, Issue 7, 1996, Pages 419-422

  Linder, Steven L ^a,b  

^a Dallas Pediatric Neurology Associates   (United States)

^b NONE   (United States)

Author keywords

acute migraine; migraine with chronic tension type headaches; migraine with episodic tension type headaches; sumatriptan

Indexed keywords

DIHYDROERGOTAMINE MESILATE; SUMATRIPTAN;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EYE DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; MALE; MIGRAINE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OTOTOXICITY; PRIORITY JOURNAL; RECURRENCE RISK; RESPIRATORY TRACT DISEASE; SENSORY DYSFUNCTION; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE;

EID: 0029768756     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3607419.x     Document Type: Article

References (4)

1. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:316-321.
2. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34:581-582.
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):10-73.
4. Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34:578-580.